Exercise-mimicking effects of betaine in chronic disease prevention and management
Narrative review. Discusses betaine as a potential exercise-mimetic candidate for chronic-disease research.
Records 221–260 of 415. Open a study to inspect the full evidence record. Source links lead directly to the publication. Updated 19 October 2026.
Mechanistic and clinical reviews (25) · Historical reports and formulation context (11) · Human observational and biomarker research (4)
Narrative review. Discusses betaine as a potential exercise-mimetic candidate for chronic-disease research.
Narrative review. Presents an early hypothesis that betaine serves as a functional methyl donor when other pathways are impaired.
Narrative review. Reviews glucose, insulin-signaling and stress-response effects reported in rodent diabetes models.
Narrative review. Summarizes a symposium on SAMe, folate and betaine mechanisms in alcohol-associated liver injury.
Narrative review. Reviews betaine transport in kidney and liver and its possible relevance to liver injury.
Narrative review. Proposes testing betaine alongside fibrates because some fibrates increase urinary betaine loss.
Original sources: PubMed
Narrative review. Reviews dose-related homocysteine lowering and the possibility that lipid increases could offset proposed vascular benefits.
Narrative review. Surveys neurological and psychiatric hypotheses involving methylation, inflammation and neurotransmission.
Narrative review. Discusses endogenous osmolytes as possible contributors to diuresis and fluid regulation.
Narrative review. Reviews betaine and chemically modified derivatives in experimental cancer research.
Narrative review. Reviews transcriptional and protein-trafficking control of renal betaine transport under osmotic stress.
Narrative review. Explains the metabolic consequences of methyl-donor shortage and BHMT-linked remethylation.
Narrative review. Reviews early performance and body-composition findings and possible metabolic mechanisms.
Narrative review. Reviews BHMT structure, enzymatic function and possible roles beyond homocysteine regulation.
Narrative review. Integrates proposed betaine pathways across brain, cardiovascular, liver and kidney disorders.
Narrative review. Discusses osmolytes including betaine as possible ways to protect the peritoneal membrane during dialysis.
Narrative review. Reviews betaine as a metabolic regulator and protein stabilizer in addition to an osmolyte.
Historical review; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Narrative review. Proposes preventive betaine use in young athletes based on brain-protection hypotheses.
Narrative review. Proposes a combined model involving betaine, tyrosine and Cordyceps for exercise adaptation.
Narrative review. Reviews early approaches to fatty liver involving vitamin E, magnesium and betaine.
Original sources: PubMed
Narrative review. Reviews recent MASLD mechanisms and concludes that clinical therapeutic efficacy remains unestablished.
Narrative review. Reviews dietary choline/betaine studies and metabolic risk associations available through 2009.
Narrative review. Discusses whether betaine-associated LDL changes could counterbalance homocysteine lowering.
Indexed letter or commentary; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed case report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Indexed clinical report; abstract unavailable. The indexed record verifies the publication and citation, but supplies no abstract. A quantitative effect or complete treatment result is not established from this record alone.
Original sources: PubMed
Diagnostic biomarker study. Urinary betaine/creatinine improved discrimination when combined with PLA2R antibodies, but broader clinical validation remained necessary.
Case-control biomarker study. Betaine was lower in coronary-disease patients with dysglycemia and inversely associated with several glycemic and metabolic measures.
Case-control study. Higher estimated betaine intake was associated with modestly lower colorectal-cancer odds, while some choline forms showed opposite associations.
Cross-sectional study. Higher dietary betaine, particularly from plant foods, was associated with lower odds of selected lipid abnormalities.
Design tiers organize different kinds of evidence; read the source-specific limitations before applying a result. The full library is curated by Biohack Blueprint. Each evidence record lists its editorial author and reviewers.